CIRRHOSISA
0
Mo1561 GUT SELECTIVE BIOLOGIC, VEDOLIZUMAB, IS ASSOCIATED WITH LOWER RATES OF LIVER RELATED COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH ...
Mo1561 GUT SELECTIVE BIOLOGIC, VEDOLIZUMAB, IS ASSOCIATED WITH LOWER RATES OF LIVER RELATED COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH ...